Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,345.00
+45.00 (1.96%)
At close: Sep 18, 2026
Kookjeon Pharmaceutical Revenue
Kookjeon Pharmaceutical had revenue of 40.48B KRW in the quarter ending June 30, 2026, with 21.43% growth. This brings the company's revenue in the last twelve months to 134.57B, down -0.37% year-over-year. In the year 2025, Kookjeon Pharmaceutical had annual revenue of 131.04B, down -3.98%.
Revenue (ttm)
134.57B
Revenue Growth
-0.37%
P/S Ratio
0.94
Revenue / Employee
756.02M
Employees
178
Market Cap
126.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.04B | -5.43B | -3.98% |
| Dec 31, 2024 | 136.47B | 14.47B | 11.86% |
| Dec 31, 2023 | 122.00B | 18.29B | 17.63% |
| Dec 31, 2022 | 103.71B | 18.36B | 21.51% |
| Dec 31, 2021 | 85.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| FarmStory | 1.44T |
| KCC Engineering & Construction | 1.28T |
| Unitrontech | 951.53B |
| DIO Corporation | 174.45B |
| C&G Hi Tech | 165.57B |
| Ghost Studio | 114.43B |
| Naintech CO.,LTD. | 71.23B |
| RAON ROBOTICS | 60.41B |